The discovery of a new molecule that’s similar to the Anandamide molecule is creating a buzz.
A newly discovered receptor appears to be a target for CBD and THC, and possibly other cannabinoids.
Animal research showed that CB3 regulates stomach & colon functions in mice, says a study published in “Current Opinion in Pharmacology.”
We already know that the cannabinoids CBD and THC are powerful anti-inflammatories.
Now a new cannabinoid – PEA – has been found to benefit the gastrointestinal system.
PEA reduces inflammation in the intestine when it connects with cannabinoid receptors CB1 and CB2 and the new kid on the block – CB3.
Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to CanaCanada and CannabisFindings.com with appropriate and specific direction to the original content.